삼중 조합 항체 치료제

본 발명은 항-TIGIT 항체, 항-PVRIG 항체, 및 항-PD-1 또는 항-PD-L1 항체를 비롯한 체크포인트 억제제의 삼중 조합 요법에 관한 것이다. The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AZULAY MEIR, LEUNG LING, WHELAN SARAH, KOTTURI MAYA, OPHIR ERAN, KUMAR SANDEEP, LIANG SPENCER, ALTEBER ZOYA, DESAI RADHIKA, CHAN CHRISTOPHER, LOGRONIO KATHRYN, MACHLENKIN ARTHUR
Format:	Patent
Sprache:	kor
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	본 발명은 항-TIGIT 항체, 항-PVRIG 항체, 및 항-PD-1 또는 항-PD-L1 항체를 비롯한 체크포인트 억제제의 삼중 조합 요법에 관한 것이다. The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.